| [1] |
Raza C, Anjum R, Shakeel N．Parkinson′s disease：mechanisms，translational models and management strategies[J]. Life Sci， 2019(226)：77-90.DOI： 10.1016/j.lfs.2019.03.057.
|
| [2] |
Simon DK, Tanner CM, Brundin P．Parkinson disease epidemiology，pathology，genetics，and pathophysiology[J]. Clin Geriatr Med， 2020， 36(1)：1-12.DOI： 10.1016/j.cger.2019.08.002.
|
| [3] |
Miller IN, Cronin-Golomb A. Gender differences in Parkinson′s disease：clinical characteristics and cognition[J]. Mov Disord， 2010， 25(16)：2695-2703.DOI： 10.1002/mds.23388.
|
| [4] |
DeMaagd G, Philip A．Parkinson′s disease and its management：Part 1：disease entity，risk factors，pathophysiology，clinical presentation，and diagnosis[J].P T，2015，40(8)：504-532.
|
| [5] |
Goldman SM, Marek K, Ottman R，et al.Concordance for Parkinson′s disease in twins：a 20-year update[J]. Ann Neurol， 2019， 85(4)：600-605.DOI： 10.1002/ana.25441.
|
| [6] |
Acar N, Parlak H, Ozkan A，et al.The effect of docosahexaenoic acid on apelin distribution of nervous system in the experimental mouse model of Parkinson′s disease[J]. Tissue Cell， 2019(56)：41-51.DOI： 10.1016/j.tice.2018.12.002.
|
| [7] |
|
| [8] |
Tatemoto K, Hosoya M, Habata Y，et al.Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor[J]. Biochem Biophys Res Commun， 1998， 251(2)：471-476.DOI： 10.1006/bbrc.1998.9489.
|
| [9] |
|
| [10] |
Pope GR, Roberts EM, Lolait SJ，et al.Central and peripheral apelin receptor distribution in the mouse：species differences with rat[J]. Peptides， 2012， 33(1)：139-148.DOI： 10.1016/j.peptides.2011.12.005.
|
| [11] |
|
| [12] |
Chen P, Wang Y, Chen L，et al.Apelin-13 protects dopaminergic neurons against rotenone-induced neurotoxicity through the AMPK/mTOR/ULK-1 mediated autophagy activation[J]. Int J Mol Sci， 2020， 21(21)：8376.DOI： 10.3390/ijms21218376.
|
| [13] |
Minakaki G, Menges S, Kittel A, et al. Autophagy inhibition promotes SNCA/alpha-synuclein release and transfer via extracellular vesicles with a hybrid autophagosome-exosome-like phenotype[J]. Autophagy， 2018， 14(1)：98-119.DOI： 10.1080/15548627.2017.1395992.
|
| [14] |
Pouresmaeili-Babaki E, Esmaeili-Mahani S, Abbasnejad M，et al.Protective effect of neuropeptide Apelin-13 on 6-Hydroxydopamine-induced neurotoxicity in SH-SY5Y dopaminergic cells：involvement of its antioxidant and antiapoptotic properties[J]. Rejuvenation Res， 2018， 21(2)：162-167.DOI： 10.1089/rej.2017.1951.
|
| [15] |
Chapman NA, Dupré DJ, Rainey JK.The apelin receptor：physiology，pathology，cell signalling，and ligand modulation of a peptide-activated class A GPCR[J]. Biochem Cell Biol， 2014， 92(6)：431-440.DOI： 10.1139/bcb-2014-0072.
|
| [16] |
Jha SK, Jha NK, Kar R, et al. p38 MAPK and PI3K/AKT signalling cascades in Parkinson′s disease[J].Int J Mol Cell Med，2015，4(2)：67-86.
|
| [17] |
Kennedy SG, Kandel ES, Cross TK，et al.Akt/Protein kinase B inhibits cell death by preventing the release of cytochrome c from mitochondria[J]. Mol Cell Biol， 1999， 19(8)：5800-5810.DOI： 10.1128/MCB.19.8.5800.
|
| [18] |
Zeng XJ, Yu SP, Zhang L，et al. Neuroprotective effect of the endogenous neural peptide apelin in cultured mouse cortical neurons[J]. Exp Cell Res， 2010， 316(11)：1773-1783.DOI： 10.1016/j.yexcr.2010.02.005.
|
| [19] |
Zou Y, Wang B, Fu W，et al.Apelin-13 protects PC12 cells from corticosterone-induced apoptosis through PI3K and ERKs activation[J]. Neurochem Res， 2016， 41(7)：1635-1644.DOI： 10.1007/s11064-016-1878-0.
|
| [20] |
Zhu J, Dou S, Jiang Y，et al.Apelin-36 exerts the cytoprotective effect against MPP(+)-induced cytotoxicity in SH-SY5Y cells through PI3K/Akt/mTOR autophagy pathway[J]. Life Sci， 2019(224)：95-108.DOI： 10.1016/j.lfs.2019.03.047.
|
| [21] |
Zhu J, Gao W, Shan X，et al.Apelin-36 mediates neuroprotective effects by regulating oxidative stress，autophagy and apoptosis in MPTP-induced Parkinson′s disease model mice[J]. Brain Res， 2020(1726)：146493.DOI： 10.1016/j.brainres.2019.146493.
|
| [22] |
Curry DW, Stutz B, Andrews ZB，et al.Targeting AMPK signaling as a neuroprotective strategy in Parkinson′s disease[J]. J Parkinsons Dis， 2018， 8(2)：161-181.DOI： 10.3233/JPD-171296.
|
| [23] |
Wang JF, Mei ZG, Fu Y，et al.Puerarin protects rat brain against ischemia/reperfusion injury by suppressing autophagy via the AMPK-mTOR-ULK1 signaling pathway[J]. Neural Regen Res， 2018， 13(6)：989-998.DOI： 10.4103/1673-5374.233441.
|
| [24] |
Darabi S, Noori-Zadeh A, Rajaei F, et al. SMER28 attenuates dopaminergic toxicity mediated by 6-Hydroxydopamine in the rats via modulating oxidative burdens and autophagy-related parameters[J]. Neurochem Res， 2018， 43(12)：2313-2323.DOI： 10.1007/s11064-018-2652-2.
|
| [25] |
Han B, Wang L, Fu F，et al.Hydroxysafflor yellow a promotes α-synuclein clearance via regulating autophagy in rotenone-induced Parkinson′s disease mice[J]. Folia Neuropathol， 2018， 56(2)：133-140.DOI： 10.5114/fn.2018.76618.
|
| [26] |
Wakatsuki S, Tokunaga S, Shibata M, et al. GSK3B-mediated phosphorylation of MCL1 regulates axonal autophagy to promote Wallerian degeneration[J]. J Cell Biol， 2017， 216(2)：477-493.DOI： 10.1083/jcb.201606020.
|
| [27] |
Hou X, Watzlawik JO, Fiesel FC，et al.Autophagy in Parkinson′s disease[J]. J Mol Biol， 2020， 432(8)：2651-2672.DOI： 10.1016/j.jmb.2020.01.037.
|
| [28] |
Yang G, Li J, Cai Y，et al.Glycyrrhizic acid alleviates 6-hydroxydopamine and corticosterone-induced neurotoxicity in SH-SY5Y cells through modulating autophagy[J]. Neurochem Res， 2018， 43(10)：1914-1926.DOI： 10.1007/s11064-018-2609-5.
|
| [29] |
Sarkar S．Regulation of autophagy by mTOR-dependent and mTOR-independent pathways：autophagy dysfunction in neurodegenerative diseases and therapeutic application of autophagy enhancers[J]. Biochem Soc Trans， 2013， 41(5)：1103-1130.DOI： 10.1042/BST20130134.
|
| [30] |
Khwanraj K, Madlah S, Grataitong K, et al. Comparative mRNA expression of eEF1A isoforms and a PI3K/Akt/mTOR pathway in a cellular model of Parkinson′s disease[J]. Parkinsons Dis， 2016(2016)：8716016.DOI： 10.1155/2016/8716016.
|
| [31] |
Alers S, Löffler AS, Wesselborg S，et al.Role of AMPK-mTOR-Ulk1/2 in the regulation of autophagy：cross talk，shortcuts，and feedbacks[J]. Mol Cell Biol， 2012， 32(1)：2-11.DOI： 10.1128/MCB.06159-11.
|
| [32] |
Mantzaris MD, Bellou S, Skiada V，et al.Intracellular labile iron determines H 2O 2- induced apoptotic signaling via sustained activation of ASK1/JNK-p38 axis[J]. Free Radic Biol Med， 2016(97)：454-465.DOI： 10.1016/j.freeradbiomed.2016.07.002.
|
| [33] |
Wu Y, Wang X, Zhou X, et al. Temporal expression of Apelin/Apelin receptor in ischemic stroke and its therapeutic potential[J]. Front Mol Neurosci， 2017(10)：1.DOI： 10.3389/fnmol.2017.00001.
|
| [34] |
Duan J, Cui J, Yang Z，et al.Neuroprotective effect of Apelin 13 on ischemic stroke by activating AMPK/GSK-3β/Nrf2 signaling[J]. J Neuroinflammation， 2019， 16(1)：24.DOI： 10.1186/s12974-019-1406-7.
|
| [35] |
Xu W, Li T, Gao L，et al.Apelin-13/APJ system attenuates early brain injury via suppression of endoplasmic reticulum stress-associated TXNIP/NLRP3 inflammasome activation and oxidative stress in a AMPK-dependent manner after subarachnoid hemorrhage in rats[J]. J Neuroinflammation， 2019， 16(1)：247.DOI： 10.1186/s12974-019-1620-3.
|
| [36] |
Cherry JD, Olschowka JA, O′Banion MK.Neuroinflammation and M2 microglia：the good，the bad，and the inflamed[J]. J Neuroinflammation， 2014(11)：98.DOI： 10.1186/1742-2094-11-98.
|
| [37] |
Li R, Liu W, Yin J，et al.TSG-6 attenuates inflammation-induced brain injury via modulation of microglial polarization in SAH rats through the SOCS3/STAT3 pathway[J]. J Neuroinflammation， 2018， 15(1)：231.DOI： 10.1186/s12974-018-1279-1.
|
| [38] |
Zhou S, Guo X, Chen S，et al.Apelin-13 regulates LPS-induced N9 microglia polarization involving STAT3 signaling pathway[J]. Neuropeptides， 2019(76)：101938.DOI： 10.1016/j.npep.2019.101938.
|
| [39] |
Chen D, Lee J, Gu X, et al. Intranasal delivery of Apelin-13 is neuroprotective and promotes angiogenesis after ischemic stroke in mice[J]. ASN Neuro， 2015， 7(5)：1759091415605114.DOI： 10.1177/1759091415605114.
|
| [40] |
Zeng R, Luo DX, Li HP，et al.MicroRNA-135b alleviates MPP(+)-mediated Parkinson′s disease in in vitro model through suppressing FoxO1-induced NLRP3 inflammasome and pyroptosis[J]. J Clin Neurosci， 2019(65)：125-133.DOI： 10.1016/j.jocn.2019.04.004.
|
| [41] |
Shacham T, Sharma N, Lederkremer GZ.Protein misfolding and ER stress in Huntington′s disease[J]. Front Mol Biosci， 2019(6)：20.DOI： 10.3389/fmolb.2019.00020.
|
| [42] |
Zhang J, Zhang Z, Bao J，et al.Jia-Jian-Di-Huang-Yin-Zi decoction reduces apoptosis induced by both mitochondrial and endoplasmic reticulum caspase12 pathways in the mouse model of Parkinson′s disease[J]. J Ethnopharmacol， 2017(203)：69-79.DOI： 10.1016/j.jep.2016.12.053.
|
| [43] |
Zhu J, Dou S, Jiang Y, et al. Apelin-13 protects dopaminergic neurons in MPTP-induced Parkinson′s disease model mice through inhibiting endoplasmic reticulum stress and promoting autophagy[J]. Brain Res， 2019(1715)：203-212.DOI： 10.1016/j.brainres.2019.03.027.
|
| [44] |
Zhu J, Dou S, Wang C，et al.Apelin-36 mitigates MPTP/MPP+-induced neurotoxicity：involvement of α-synuclein and endoplasmic reticulum stress[J]. Brain Res， 2019(1721)：146334.DOI： 10.1016/j.brainres.2019.146334.
|
| [45] |
朱俊鸽．Apelin-36在MPTP诱导的帕金森病模型小鼠中的神经保护作用及机制研究[D] .济南：山东大学，2020.
|
| [46] |
Kin K, Yasuhara T, Kameda M，et al.Animal models for Parkinson′s disease research：trends in the 2000s[J]. Int J Mol Sci， 2019， 20(21)：5402.DOI： 10.3390/ijms20215402.
|